Sort
35,931 grants matching “parkinsons”
Dopamine Mechanisms and Receptors in Raphe 5-HT Neurons
$273,729State University Of New York At Buffalo · R01 · FY2003 · MH
Expression Analysis and Genomic Convergence in PD
$273,722Michael A Hauser · University Of Miami School Of Medicine · P50 · FY2008 · NS
DROSOPHILA MODELS FOR PARKINSON'S DISEASE
$273,721Nancy M Bonini · University Of Pennsylvania · P01 · FY2008 · AG
CRCNS Detailed multi-neuron coding of decisions in parietal cortex
$273,716Jonathan William Pillow · University Of Texas At Austin · R01 · FY2012 · MH
Levodopa Pharmacokinetics and Pharmacodynamics
$273,672John G Nutt · Oregon Health & Science University · R01 · FY2007 · NS
Structure/Function Studies of Quinone Reductase 2
$273,646Zhongtao Zhang · New York Medical College · R01 · FY2007 · NS
Structure/Function Studies of Quinone Reductase 2
$273,646Zhongtao Zhang · New York Medical College · R01 · FY2008 · NS
Alpha Synuclein, cellular dysfunction and Parkinson disease
$273,637Mark Cookson · National Institute On Aging · ZIA · FY2017 · AG
Pathogenic Mechanisms of Dynactin p150glued in ALS and Parkinson's Disease
$273,637Huaibin Cai · National Institute On Aging · ZIA · FY2017 · AG
Function and Pathogenic Mechanism of alpha-synuclein in Parkinson's Disease
$273,637Huaibin Cai · National Institute On Aging · ZIA · FY2017 · AG
Structure and Function of U6 Spliceosomal RNA
$273,585Samuel E Butcher · University Of Wisconsin-Madison · R01 · FY2007 · GM
Structure and Function of U6 Spliceosomal RNA
$273,585Samuel E Butcher · University Of Wisconsin-Madison · R01 · FY2009 · GM
Structure and Function of U6 Spliceosomal RNA
$273,585Samuel E Butcher · University Of Wisconsin-Madison · R01 · FY2008 · GM
Arrestin interactions with non-receptor binding partners
$273,537Vsevolod V. Gurevich · Vanderbilt University · R01 · FY2010 · GM
Conformational dynamics, binding and aggregation of intrinsically disordered proteins
$273,519Sara M. Vaiana · Arizona State University-Tempe Campus · R01 · FY2021 · GM
Interactions of Protein Aggregation in Parkinson's Dementia
$273,476Benoit I Giasson · University Of Pennsylvania · P50 · FY2008 · NS
The PINK1 Mitochondrial Signaling Pathway
$273,352Lian Li · Emory University · R01 · FY2009 · GM
Biology of Tauopathies Studied with HSV Amplicons
$273,324E. Antonio Chiocca · Ohio State University · R01 · FY2007 · NS
Neurotoxic Mechanisms of Reactive Nitrogen Intermediates
$273,270Harry Ischiropoulos · Children'S Hosp Of Philadelphia · R01 · FY2008 · AG
Gene Therapy And Neurodegeneration
$273,270Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2012 · DA
Mutational and evolutionary impact of mitochondrial dysfunction
$273,203Dee R Denver · Oregon State University · R01 · FY2011 · GM
A Conserved Metalloprotease Required for Mitochondrial Maintenance and Protection
$273,189Oleh Khalimonchuk · University Of Nebraska Lincoln · R01 · FY2017 · GM
A Conserved Metalloprotease Required for Mitochondrial Maintenance and Protection
$273,189Oleh Khalimonchuk · University Of Nebraska Lincoln · R01 · FY2018 · GM
A Conserved Metalloprotease Required for Mitochondrial Maintenance and Protection
$273,189Oleh Khalimonchuk · University Of Nebraska Lincoln · R01 · FY2016 · GM
A Conserved Metalloprotease Required for Mitochondrial Maintenance and Protection
$273,189Oleh Khalimonchuk · University Of Nebraska Lincoln · R01 · FY2014 · GM